Minimally invasive surgical approaches offer earlier time to adjuvant chemotherapy but not improved survival in resected pancreatic cancer

被引：0
|
作者：
Katelin A. Mirkin
Erin K. Greenleaf
Christopher S. Hollenbeak
Joyce Wong
机构：
[1] The Pennsylvania State University,Division of Surgical Oncology, Department of Surgery, College of Medicine
[2] The Pennsylvania State University,Department of Public Health Sciences, College of Medicine
来源：
Surgical Endoscopy | 2018年 / 32卷
关键词：
Pancreatic cancer; Minimally invasive surgery; MIS; Time to adjuvant therapy; NCDB;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：2387 / 2396
页数：9
相关论文
共 50 条
  • [1] Minimally invasive surgical approaches offer earlier time to adjuvant chemotherapy but not improved survival in resected pancreatic cancer
    Mirkin, Katelin A.
    Greenleaf, Erin K.
    Hollenbeak, Christopher S.
    Wong, Joyce
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (05): : 2387 - 2396
  • [2] Minimally Invasive Surgical Approaches Offer Earlier Time to Adjuvant Chemotherapy but Are Not Yet Associated with Improved Survival in Resected Pancreatic Cancer
    Mirkin, Katelin A.
    Greenleaf, Erin K.
    Hollenbeak, Christopher S.
    Wong, Joyce
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : S76 - S77
  • [3] Time to Initiation of Adjuvant Chemotherapy Does Not Impact Survival in Resected Pancreatic Cancer
    Mirkin, K. A.
    Hollenbeak, C. S.
    Wong, J.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S173 - S173
  • [4] Effect of time to initiation of adjuvant chemotherapy on survival in resected pancreatic cancer.
    Mirkin, Katelin Anne
    Hollenbeak, Christopher S.
    Wong, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] Time to the Initiation of Adjuvant Chemotherapy Does Not Impact Survival in Patients With Resected Pancreatic Cancer
    Mirkin, Katelin A.
    Greenleaf, Erin K.
    Hollenbeak, Christopher S.
    Wong, Joyce
    CANCER, 2016, 122 (19) : 2979 - 2987
  • [6] Minimally Invasive Approaches to Pancreatic Cancer
    Broucek, Joseph R.
    Sanford, Dominic
    Stauffer, John A.
    Asbun, Horacio J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 28 (02) : 255 - +
  • [7] Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer
    Tran, Andy
    Zheng, Richard
    Johnston, Fabian
    He, Jin
    Burns, William R.
    Shubert, Christopher
    Lafaro, Kelly
    Burkhart, Richard A.
    HPB, 2024, 26 (10) : 1280 - 1290
  • [8] Gemcitabine/taxane adjuvant therapy in resected pancreatic cancer: A signal of improved survival?
    Kanji, Zaheer S.
    Edwards, Alicia M.
    Mandelson, Margaret T.
    Lin, Bruce
    Badiozamani, Kasra
    Song, Goubin
    Alseidi, Adnan
    Biehl, Thomas
    Kozarek, Richard A.
    Helton, William Scott
    Picozzi, Vincent J.
    Rocha, Flavio G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [9] The Addition of Radiation Therapy to Adjuvant Chemotherapy is Associated With Improved Overall Survival in Resected Pancreatic Adenocarcinoma
    Rutter, C. E.
    Park, H. S. M.
    Corso, C. D.
    Lester-Coll, N. H.
    Mancini, B. R.
    Yeboa, D. N.
    Johung, K. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S154 - S155
  • [10] Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I-II pancreatic cancer
    Ma, Sung Jun
    Hermann, Gregory M.
    Prezzano, Kavitha M.
    Serra, Lucas M.
    Iovoli, Austin J.
    Singh, Anurag K.
    CANCER MEDICINE, 2019, 8 (03): : 939 - 952
12345